We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Croda International Plc | LSE:CRDA | London | Ordinary Share | GB00BJFFLV09 | ORD 10.609756P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
57.00 | 1.22% | 4,711.00 | 4,706.00 | 4,709.00 | 4,775.00 | 4,649.00 | 4,678.00 | 145,556 | 13:36:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 1.69B | 171M | 1.2246 | 38.62 | 6.6B |
TIDMCRDA
RNS Number : 7757L
Croda International PLC
31 December 2018
Croda International Plc ("Croda")
Acquisition of leading global vaccine adjuvant specialist
Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018. Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.
-ENDS-
For enquiries contact:
Conleth Campbell, VP Investor Relations, Investors: Croda +44 1405 860551 Press: Charlie Armitstead, Teneo +44 7703 330269
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ACQFKKDQDBDBDBN
(END) Dow Jones Newswires
December 31, 2018 02:00 ET (07:00 GMT)
1 Year Croda Chart |
1 Month Croda Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions